CX Institutional’s XPeng XPEV Stock Holding History

CX Institutional’s Portfolio XPEV Stock Details XPEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-215	Closed	-$7K	–	1143
2022 Q2	$7K	Buy	+215	New	+$5.53K	﹤0.01%	1004

Other funds holding XPEV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

PCM

Primavera Capital Management George Town, Cayman Islands $648M AUM 6.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

CX Institutional's XPEV Position: Q3 2022 in Review

CX Institutional sold out of XPeng (XPEV) in Q3 2022, closing a stake of 215 shares — an estimated $7K sold.

CX Institutional first reported a position in XPEV in Q2 2022 and held it in 1 quarter. The position peaked at $7K in Q2 2022. 263 funds tracked by Wall St. Rank hold XPEV as of Q3 2022.

CX Institutional reported no remaining XPeng position as of Q3 2022 after selling out during the quarter.
CX Institutional sold 215 XPeng shares in Q3 2022, an estimated $7K.
CX Institutional first reported a position in XPeng in Q2 2022 and held it in 1 quarter.
CX Institutional's XPeng position peaked at $7K in Q2 2022.
263 funds tracked by Wall St. Rank held XPeng as of Q3 2022.

Based on CX Institutional's 13F filing for Q3 2022, filed 4 Nov 2022.